Loading organizations...
Tanis Venture Management operates as a venture capital firm, providing strategic investment to early-stage technology companies. The firm focuses its capital deployment within the B2B, healthcare, information technology, and life science sectors. A key aspect of its approach involves supporting portfolio companies by facilitating access to non-dilutive research and development funding, thereby optimizing capital structures and enabling sustained innovation.
The firm was co-founded in 2019 by Alexander Seaver, Jack Seaver, and Bradley Kent. Alexander Seaver brings extensive investment experience, having co-founded Stadium Capital Management in 1997 and previously serving as a Partner at Interwest Venture Management. Bradley Kent also co-founded Stadium Capital Management, where he functioned as a portfolio manager. Jack Seaver serves as a managing partner, collectively leveraging their deep financial and entrepreneurial backgrounds to identify and nurture promising ventures.
Tanis Venture Management targets compelling early-stage companies poised for growth within their specialized sectors. The firm’s vision centers on fostering the development of innovative businesses that benefit from both direct investment and strategic guidance, particularly in navigating complex funding landscapes. It aims to empower these companies to achieve their long-term potential, contributing to advancements across critical industries.
Tanis Venture Management has 2 tracked investments across 2 companies. The latest tracked deal is $20.0M Series A in Seasats in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 17, 2026 | Seasats | $20.0M Series A | Konvoy Ventures | Crumpton Ventures, DNS Capital, Dorado Group, Shield Capital, Techstars |
| Apr 19, 2024 | Corner Therapeutics | $54.0M Series A | Ziff Capital Partners | Sandia Holdings |